Sign inJoin waitlistJoin the waitlist

Zhen Zhou

Clinical Assistant Professor of Obstetrics and Gynecology · University of Michigan

Credentials: · · · · ·

History

University of Michigan
Present

Gynecologic Oncology
University of Michigan
2021–2024
Obstetrics and Gynecology
2017–2021
Albert Einstein College of Medicine
2011–2015

Research

Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center
Journal of General Internal Medicine · 2021 · 149 citations
Perioperative Morbidity and Mortality of Patients With COVID-19 Who Undergo Urgent and Emergent Surgical Procedures
Annals of Surgery · 2021 · 125 citations
Contribution of CXCL12 secretion to invasion of breast cancer cells
Breast Cancer Research · 2012 · 93 citations

KH
Kevin Holcomb
7 papers
Eloise Chapman-Davis
6 papers
Melissa Frey
5 papers
Alexander Melamed
3 papers · 1 as a fellow
Caryn Clair
3 papers
Dawn Hershman
3 papers
Fady Collado
3 papers
Jason Wright
3 papers
June Hou
3 papers
AT
Ana Tergas
2 papers · 2 as a fellow
Anne Knisely
2 papers · 2 as a resident
Evelyn Cantillo
2 papers

Clinical trials

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2026–2028
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2025–2030
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2034
Study of ACR-2316 in Specific Advanced Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
Acrivon Therapeutics
2024–2027